US Stock MarketDetailed Quotes

PCH PotlatchDeltic Corp

Watchlist
  • 44.270
  • -0.950-2.10%
Close Mar 25 16:00 ET
  • 44.270
  • 0.0000.00%
Post 16:27 ET
3.49BMarket Cap158.11P/E (TTM)

PotlatchDeltic Corp Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

PotlatchDeltic Corp Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 7 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 270.474M--
--2025/Q1-- / 243.677M--
--2024/Q4258.147M / 247.163M--
--2024/Q3255.131M / 241.347M--
--2024/Q2320.671M / 305.002M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 270.474M--
--2025/Q1-- / 243.677M--
--2024/Q4258.147M / 247.163M--
--2024/Q3255.131M / 241.347M--
--2024/Q2320.671M / 305.002M--

Unlock Free Earnings Estimates

PotlatchDeltic Corp Earnings Reports

  • PotlatchDeltic Corp | 10-K: FY2024 Annual Report

    Feb 13 14:34 ET

  • PotlatchDeltic Corp | 8-K: PotlatchDeltic Corporation Reports Fourth Quarter and Full Year 2024 Results

    Jan 27 16:14 ET

  • PotlatchDeltic Corp | 10-Q: Q3 2024 Earnings Report

    Nov 4, 2024 13:55 ET

  • PotlatchDeltic Corp | 8-K: PotlatchDeltic Corporation Reports Third Quarter 2024 Results

    Oct 28, 2024 16:17 ET

    • Read more

    Market Insights
    Best Growth Stocks Best Growth Stocks

    Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

    Symbol Mini Chart % Chg
    Enerpac Tool
    EPAC
    +8.39%
    Precision Drilling
    PDS
    +2.04%
    Halozyme Therapeutics
    HALO
    +1.28%
    Workday
    WDAY
    +1.17%
    Lantheus
    LNTH
    +0.33%

    Unlock the Full List

    Analysis

    Analyst Rating

    Updated: Mar 23, 2025

    Strong Buy

    • Buy

      80.00%

    • Hold

      20.00%

    • Sell

      0.00%

    Price Target

    No Data